MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,000 | 0.0% | 200 | +25.0% | 0.00% | -33.3% |
| Q3 2019 | $5,000 | +25.0% | 160 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $4,000 | -20.0% | 160 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $5,000 | 0.0% | 160 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | -44.4% | 160 | -20.0% | 0.00% | -40.0% |
| Q3 2018 | $9,000 | +28.6% | 200 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,000 | -99.9% | 200 | -33.3% | 0.00% | -42.9% |
| Q3 2017 | $10,854,000 | +40.0% | 300 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $7,752,000 | +39.7% | 300 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $5,550,000 | +110900.0% | 300 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $5,000 | -50.0% | 300 | 0.0% | 0.00% | -57.1% |
| Q2 2016 | $10,000 | +100.0% | 300 | +114.3% | 0.01% | +133.3% |
| Q1 2016 | $5,000 | – | 140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
| Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
| ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
| EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
| AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
| Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
| Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |